Skip to content
Search

Latest Stories

'Rise in violence against pharmacists is forcing them to look for work elsewhere'

Violent and abusive behaviour against pharmacists is impacting on recruitment and retention of staff in the sector, according to the Pharmacists’ Defence Association (PDA).

The trade union for pharmacists told BBC Breakfast TV on Wednesday (May 8) that its members have continuously raised workplace safety concerns due to an alarming rise in the incidents of abuse and violence against pharmacy staff.


The PDA union has been calling for adequate risk assessments and preventative safety measures to be put in place in pharmacies whist adopting a zero-tolerance approach to violence and abuse.

With several significant and worrying incidents involving PDA members, including a pharmacist being threatened with a knife recently, further research was conducted in April 2022 to establish the extent and impact of such behaviour on pharmacists.

Forty-four per cent of the respondents in the survey reported that they or someone that they worked with had experienced physical or violent abuse in the last month.

Eighty-five per cent of pharmacists surveyed said they or someone they worked with had experienced verbal or racial abuse in the last month, with 89 per cent confirming there had been an increase in the number of such incidents in the last year.

However, only 38 per cent of the respondents had logged a police report in relation to physical violence or abuse, property damage or theft.

Last year, the result of the PDA’s 2021 safer pharmacies survey also demonstrated the scale of the problem, with only two in 10 pharmacists reporting that they felt safe all of the time that they were at work.

The association stressed that the main reasons for the number of incidents occurring included inadequate staffing levels, frustration from patients around the time taken to dispense their prescriptions and some cases of medicines being unavailable.

In a statement, Alison Jones, director of policy at the PDA, said: “People are understandably anxious about their health or that of those that they care for, and are visiting pharmacies more as they are an accessible and convenient way to seek the advice of a healthcare professional.

However, there are necessary and regulated checks which need to take place with every prescription item that is dispensed – to make sure that the medicines are safe and appropriate for the individual. This important safety net means that it can take a little time for patients to wait in the pharmacy and this is often where flash points can occur."

Data from Health Education England’s (HEE) pharmacy workforce survey for 2021 demonstrates that there has been a significant reduction in staff working in community pharmacy in recent years, with a drop in the number of support staff since 2017 of a staggering 14 per cent on a full-time equivalent basis, even though since the start of the Covid-19 pandemic, 31 per cent of people are more likely to visit a pharmacy first before seeking help elsewhere.

Alison continued: “Pharmacists and pharmacy teams need to feel safe in their workplace and there is no excuse for them to be subjected to the violence and abuse that we are hearing about from our members.

“The PDA continues to call for pharmacy businesses to adopt the Safer Pharmacies Charter, which includes a commitment around a zero-tolerance approach to violence and abuse, and for teams to be appropriately protected from the often-daily threats that they are experiencing through the provision of appropriate staffing levels and security measures such as panic alarms and CCTV”.

Some PDA members told the union that they are anxious about going to work and do not feel supported by their management resulting in them looking to work elsewhere.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less